The function of PCSK9 was not only to regulate cholesterol and prevent cardiovascular diseases, but also to potentiate the application of PCSK9 inhibitors in ischemia-reperfusion injury and enhance the synergistic anticancer effect of PD-1. Here, PDCD1 is linked to cardiovascular disorder.